KEDI Palantir Fixed Tech100 Index

Q3 2026 earnings release scheduled; significant price impact from the previously guided approximately $29.4 billion revenue is expected.

Q2 fiscal 2027 earnings release scheduled. Analysts forecast strong growth, and a >10% price impact is estimated. scheduled

NVIDIA is scheduled to report its Q2 FY2027 earnings on August 26, 2026. High importance is estimated due to the company's significant market influence; analysts forecast EPS around $2.01-$2.09 and revenue guidance is approximately $91 billion forecasted. This event is scheduled.

Baidu is scheduled to announce its Q2 2026 financial results on 2026-08-26. Analysts forecast revenue around 32.2 billion RMB, with focus on AI business growth amid a soft advertising market scheduled.

Next quarterly earnings release for Q2 Fiscal 2027 is scheduled. Low importance is estimated as the market typically reacts to the actual results rather than the scheduling announcement.

Intuit's Q4 and full-year fiscal 2026 earnings release on 2026-08-20; low impact estimated as a routine announcement, expected.

Third quarter fiscal year 2026 financial results, with medium impact estimated due to historical earnings volatility, scheduled.

Palo Alto Networks is scheduled to report its fiscal Q4 2026 financial results on 2026-08-17; these releases typically result in high price volatility exceeding 10%, scheduled.

Q3 2026 earnings report and conference call, estimated ~1% price impact, scheduled.

Cisco is scheduled to announce its Q4 and full-year fiscal 2026 financial results after the market close on August 12, 2026; analysts forecast EPS of approximately $1.13. Medium importance is estimated as earnings releases typically drive significant price movement scheduled.

The ex-dividend date for the quarterly cash dividend of $0.27 per share is scheduled for August 11, 2026, scheduled.

First major IPO lock-up period expiration scheduled for 2026-08-08, occurring two trading days after the Q2 earnings report. This could allow up to 911.5 million shares to be sold, creating potential for significant selling pressure scheduled.

Datadog announced it will report its second quarter fiscal year 2026 financial results on August 6, 2026, before the U.S. financial markets open. This event is estimated to have a >10% price impact, scheduled.

Natera is scheduled to release its Q2 2026 financial results after the market closes on August 6, 2026. This is a recurring, significant event, and its importance is estimated as High based on substantial market reactions to past earnings reports scheduled.

Q2 2026 earnings release and conference call on August 6, 2026, scheduled.

Microchip's Q1 fiscal 2027 earnings release is scheduled for August 6, 2026, based on past reporting schedules. Analysts forecast EPS of around $0.70 forecasted.

Q2 2026 earnings release and conference call scheduled.

Shopify is scheduled to announce its Q2 2026 financial results before markets open on August 5, 2026, with a conference call to follow. High importance is estimated due to historical price volatility exceeding 10% following earnings releases scheduled.

Q2 2026 earnings release and conference call scheduled. Analysts forecast EPS of approximately $3.72. Medium importance is assigned as quarterly results typically trigger price movements of 5% or more, which is expected.

AMD is scheduled to report its Q2 2026 financial results after market close on August 4, 2026. High importance is estimated as earnings for major tech firms typically drive >10% volatility, scheduled.

Amgen is scheduled to report its Q2 2026 financial results after the market closes on August 4, 2026; a high impact is estimated as quarterly earnings typically drive significant volatility, scheduled.

Q2 2026 financial results and conference call scheduled. Importance is estimated as High due to the significant potential for market reaction to earnings announcements, scheduled.

Palantir Technologies to release second-quarter 2026 financial results after market close on August 3, 2026, scheduled. High impact estimated as earnings are primary volatility drivers for growth stocks.

Linde Plc is scheduled to release its second quarter 2026 financial results on July 31, 2026, before the market opens; Medium importance estimated based on historical earnings volatility scheduled

Quarterly cash dividend of $1.42 per share, with an ex-dividend date of July 31, 2026. The dividend is payable on August 11, 2026 scheduled

Alnylam is scheduled to report its financial results for the second quarter ending June 30, 2026, before the U.S. financial markets open, as announced on July 16, 2026. High importance is estimated as earnings reports for major biotech firms often result in ≥10% price impact. The event is scheduled.

Amazon's second quarter 2026 financial results release is set for July 30, 2026; high impact expected due to historical earnings volatility scheduled.

Monolithic Power Systems is scheduled to report its second quarter 2026 financial results after the market closes on July 30, 2026, followed by a Q&A webinar; high importance estimated due to potential for significant price volatility scheduled.

Apple will announce its Q3 2026 earnings results after the market closes on July 30, 2026. Analysts forecast EPS to be around $1.88, an increase from the prior year. A neutral impact is estimated as the market awaits the actual performance relative to these forecasts, scheduled.

Regeneron is scheduled to report its second quarter 2026 financial and operating results on 2026-07-30; a medium impact is estimated as earnings reports typically drive significant volatility, scheduled.

Q2 2026 earnings release scheduled for 2026-07-30; analysts forecast revenue of approximately $12.6 billion. Medium importance as earnings typically drive 5-10% price movement, scheduled.

Automatic Data Processing Inc. is scheduled to release its financial results for the fourth quarter and full fiscal year 2026 before the market opens on July 29, 2026, with a conference call to follow. This major annual earnings release is expected to have a significant market impact exceeding 10% based on historical volatility scheduled.

Lam Research's Q4 2026 earnings is scheduled for July 29, 2026. Analysts forecast EPS of $1.68 to $1.69, which would be a significant year-over-year increase, forecasted. High importance is estimated due to historical earnings volatility, scheduled.

Meta Platforms is scheduled to release its Q2 2026 financial results after market close on July 29, 2026, followed by a conference call; high impact is estimated as earnings reports typically drive significant volatility, and the release is scheduled.

Microsoft is scheduled to release its fiscal fourth-quarter 2026 earnings after the market closes on July 29, 2026; neutral impact estimated as market reaction depends on Azure growth and AI capital expenditure returns, scheduled

Qualcomm's third quarter fiscal 2026 earnings release and conference call on July 29, 2026, are expected to have a high price impact, though the reaction is not yet known, scheduled.

Fortinet is scheduled to announce its second quarter 2026 financial results after the market closes on July 29, 2026. Analysts forecast EPS of approximately $0.66-$0.75, while the company's guidance is for EPS of $0.72-$0.76 and revenue of $1.83-$1.93 billion. Medium importance estimated based on historical price volatility following earnings releases scheduled.

Biogen is scheduled to report its Q2 2026 financial results on July 29, 2026, before the market opens; a price impact of at least 1% is estimated based on historical earnings volatility, scheduled.

Q1 2027 earnings release on July 29, 2026, scheduled. Low importance is estimated as the company may not host a conference call due to the pending acquisition.

Teradyne is scheduled to release its Q2 2026 financial results on July 28, 2026. Analysts forecast earnings of $2.04 per share. High importance estimated due to previous quarter's 19.4% price movement scheduled.

Q4 2026 earnings release and conference call scheduled; medium impact expected as earnings are key volatility drivers.

Declared a regular quarterly cash dividend of $1.19 per share on July 16, 2026, with an ex-dividend date of July 28, 2026.

Q2 2026 earnings results and conference call on July 27, 2026. This is a recurring event with high potential for stock price impact scheduled.

AMD is scheduled to hold its flagship 'Advancing AI 2026' event on July 23, 2026. High importance is estimated due to anticipated major product announcements in the AI sector, scheduled.

Q2 2026 earnings release for Honeywell Technologies following the Aerospace spin-off; analysts forecast EPS of $1.79-$1.81; high volatility expected for the first post-restructuring report scheduled.

Intel Q2 2026 earnings report on July 23, 2026; analysts forecast EPS of $0.10-$0.21, with options market pricing a >15% move scheduled.

Q2 2026 earnings release with an EPS of approximately $0.97 analysts forecasted is scheduled. A 5% price impact is estimated based on historical earnings surprises.

Alphabet is scheduled to release its second-quarter 2026 financial results after the market closes on July 22, 2026; analysts forecast focus on Google Cloud and AI growth, with high importance estimated.

Tesla is scheduled to report its Q2 2026 financial results on July 22, 2026; analysts forecast earnings per share of $0.52-$0.54. High importance is estimated based on historical earnings volatility exceeding 10%, scheduled.

Texas Instruments is scheduled to release its Q2 2026 earnings results after the market closes on July 22, 2026. Analysts forecast EPS of approximately $1.91 on revenue of $5.23 billion, with the options market pricing a potential price move of over 11% scheduled

Starship Flight 13 test launch scheduled for 2026-07-20. This follows a last-second abort of the previous attempt on July 16 due to engine ignition issues, which caused the stock to drop over 4% scheduled.

On July 18, 2026, news emerged that Chinese competitor ChangXin Memory Technologies (CXMT) filed for a large IPO to expand DRAM production, raising concerns about future oversupply and contributing to a recent decline in Micron's stock price.

Stock price dropped over 10% on July 17, 2026. Reports suggest the drop was not tied to a specific company announcement but rather profit-taking ahead of earnings, valuation concerns, and potential regulatory headwinds.

Completion of the acquisition of Johnson Matthey's Catalyst Technologies business for £1.325 billion on 2026-07-17; medium price impact estimated from business expansion scheduled.

NASA awarded SpaceX a contract on 2026-07-17 to provide Starlink laser communications for the Artemis III mission, aiming to enhance data transmission capabilities for the 2027 lunar mission.

Baidu announced on 2026-07-16 that its board approved a motion to pursue a voluntary conversion of its secondary listing in Hong Kong to a dual-primary listing, expected to be effective within 2026. This structural change is expected to drive significant liquidity and Stock Connect inclusion, with an estimated price impact of over 10% expected.

Announced a definitive agreement to acquire the intellectual property of XM Cyber on July 16, 2026, as part of an expanded strategic partnership with Schwarz Digits.

Q2 2026 earnings report on July 16, 2026, with $2.89B revenue and $2.80 EPS beating estimates, but lowered guidance led to a >12% price drop, expected.

NVIDIA announced a partnership with Japan's Noetra consortium on July 16, 2026, to build a national AI factory powered by 27,500 Rubin GPUs and 13,750 Vera CPUs.

Stock closed at $131.11 on 2026-07-16, the first time it closed below its $135 IPO price. The decline was part of a larger sell-off that erased approximately $1 trillion in market value from its peak on June 16.

Announced a long-term strategic partnership with Standard Chartered to modernize the bank's global infrastructure in 54 markets using VMware Cloud Foundation.

Netflix released its Q2 2026 earnings, reporting revenue of $12.56 billion and an EPS of $0.80. The company provided weak guidance for Q3, causing the stock to drop approximately 8-9% in after-hours trading.

Analysts at Oppenheimer raised the stock price target to $260 from $200, citing strong AI-driven demand forecasted.

Q2 2026 earnings beat expectations with net sales of €9.3 billion and net income of €2.9 billion. The company raised its full-year 2026 sales forecast to €43-45 billion and provided strong Q3 guidance. On the same day, ASML announced that Intel has started using its new High-NA EUV technology in high-volume production, a key milestone.

Announced the successful full-duration burn of a second-stage Archimedes engine for the Neutron rocket on July 15, 2026; estimated >10% price impact as a critical technical milestone.

Alnylam announced progress in its neuroscience portfolio at the AAIC 2026 conference, including the initiation of a Phase 2 study of mivelsiran for Alzheimer's disease and the completion of enrollment for a separate Phase 2 study in cerebral amyloid angiopathy (CAA).

Significant insider selling by executives, including the COO selling over $12M in shares on July 15 and the CTO selling shares on July 14, contributed to a stock decline; estimated >5% impact based on transaction volume, estimated.

Appointed AJ Shipley as the new Chief Product Officer (CPO) on July 15, 2026.

On July 15, 2026, Datadog announced it was named a Leader in the 2026 Gartner® Magic Quadrant™ for Observability Platforms for the sixth consecutive year. This positive recognition is estimated to have a >1% price impact.

CEO Andrew Wilson and President Laura Miele sold company stock totaling over $1.5 million under pre-arranged 10b5-1 trading plans on July 15, 2026.

President and CEO Gregory Smith sold 4,000 shares for approximately $1.43 million on July 15, 2026, under a pre-arranged 10b5-1 trading plan.

Biogen presented detailed Phase 2 data for its Alzheimer's drug diranersen at the AAIC conference on July 14, 2026. The data showed mixed results, with the study technically failing its primary endpoint due to an inverse dose response, causing the stock to drop over 8%.

Shares fell over 12% on July 13, 2026, after a report citing third-party data indicated a potential slowdown in new e-commerce advertiser growth in June.

The U.S. FDA approved LEQEMBI IQLIK, a subcutaneous (at-home) injection, as an initiation dose for early Alzheimer's disease on July 13, 2026. This provides a more convenient alternative to IV infusions, and the stock rose approximately 5% on the news.

A securities fraud class action lawsuit was filed on 2026-07-13, alleging misleading statements regarding TurboTax's growth prospects.

News reports highlighted that corporate insiders sold $31.2 million worth of shares over the last three months with no corresponding purchases.

Analysts at KeyCorp reiterated an "Overweight" rating and a $2,000 price target on the stock, forecasting FY2026 EPS of $21.05, above the consensus of $20.23 forecasted.